176694-36-3

Basic information

• Product Name: Methyl 4-fluoro-3-(trifluoroMethyl)benzoate
• Synonyms: 4-Fluoro-3-trifluoromethylbenzoic acid methyl ester;Methyl 4-fluoro-3-(trifluoroMethyl)benzoate;Benzoic acid, 4-fluoro-3-(trifluoroMethyl)-, Methyl ester
• CAS NO: 176694-36-3
• Molecular Formula: C₉H₆F₄O₂
• Molecular Weight: 222.1363528
• Mol File: 176694-36-3.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 218.553°C at 760 mmHg
• Flash Point: 83.741°C
• Appearance: /
• Density: 1.346g/cm³
• Vapor Pressure: 0.125mmHg at 25°C
• Refractive Index: 1.434
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: Methyl 4-fluoro-3-(trifluoroMethyl)benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 4-fluoro-3-(trifluoroMethyl)benzoate(176694-36-3)
• EPA Substance Registry System: Methyl 4-fluoro-3-(trifluoroMethyl)benzoate(176694-36-3)

Safety Data

• Hazardous Substances Data: 176694-36-3(Hazardous Substances Data)

Usage

General Description

Methyl 4-fluoro-3-(trifluoromethyl)benzoate is a chemical compound with the molecular formula C10H6F4O2. It is a fluoroalkyl benzoate derivative, which means it is a benzoate ester that contains a fluorine atom and a trifluoromethyl group attached to the benzene ring. Methyl 4-fluoro-3-(trifluoroMethyl)benzoate is commonly used as a building block in organic synthesis and pharmaceutical research due to its unique chemical and physical properties. It is also utilized in the production of agrochemicals, pharmaceuticals, and materials science. Methyl 4-fluoro-3-(trifluoromethyl)benzoate is often used as a reagent in chemical reactions, and its precise structure and properties make it useful in a variety of applications.

InChI:InChI=1/C9H6F4O2/c1-15-8(14)5-2-3-7(10)6(4-5)9(11,12)13/h2-4H,1H3

Upstream product

• 67-56-1 methanol 
• 67515-55-3 4-fluoro-3-(trifluoromethyl)benzoic acid 
• 18107-18-1 diazomethyl-trimethyl-silane 

Downstream Products

• 1005408-85-4 methyl 4-(octylthio)-3-(trifluoromethyl)benzoate 
• 1195951-84-8 C₂₅H₁₇Cl₂F₃N₂O₄ 
• 1192847-36-1 C₁₁H₆Br₂F₃N₃O₂ 
• 1195951-86-0 C₃₁H₂₈Cl₂F₃N₃O₅ 
• 1195951-87-1 C₂₇H₂₀Cl₂F₃N₃O₅ 
• 1195951-85-9 C₂₄H₁₅Cl₂F₃N₂O₄ 
• 1393368-57-4 1H-pyrrole-2-carboxylic acid [1-(4-guanidinocarbonyl-2-trifluoromethyl-phenyl)piperidin-3-yl]amide trifluoroacetic acid 
• 1393368-55-2 C₁₈H₁₉F₃N₆O₂ 
• 1393368-46-1 C₂₇H₂₇F₃N₆O₄ 
• 1393368-39-2 1H-pyrrole-2-carboxylic acid [1-(4-(N-carbobenzyloxy)guanidinocarbonyl-2-trifluoromethyl-phenyl)pyrrolidin-3-yl]amide 
• 1393368-45-0 4-{4-[(1H-pyrrole-2-carbonyl)amino]piperidin-1-yl}-3-trifluoromethylbenzoic acid 

Relevant articles and documents

FUSED TRICYCLIC AMIDE COMPOUNDS AS MULTIPLE KINASE INHIBITORS

Provided are fused tricyclic amide compounds, pharmaceutical compositions comprising at least one such fused tricyclic compound, processes for the preparation thereof, and the use thereof in therapy. Disclosed herein are certain tricyclic amide compounds that can be useful for inhibiting multiple (specifically BRAF and/or EGFR-T790M) kinases and for treating disorders mediated thereby.

GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE

The present invention relates to compounds of general formula (I), wherein ring A, ring B, R1, R2, R3, Z, and L1 are selected independently of each other and are as defined herein, to compositions comprising the compounds, and methods of using the compounds as glucagon receptor antagonists and for the treatment or prevention of type 2 diabetes and conditions related thereto.

CHEMICAL COMPOUNDS

The invention provides compounds formula I, their preparation, and their use as pharmaceutically active immunosuppressive agents for the treatment of autoimmune disorders, organ transplant rejection, disorders associated with an activated immune system, a